Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 725 of 994 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/06/17
End: 02/04/19
Due: 02/04/20
Phase: N/A
Priority: Normal
Start: 10/01/04
End: 05/27/09
Due: 05/27/10
Phase: N/A
Priority: Normal
Start: 09/29/98
End: 12/13/99
Due: 12/13/00
Phase: N/A
Priority: Normal
Start: 09/04/13
End: 11/17/16
Due: 11/17/17
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 07/05/18
End: 01/16/20
Due: 01/16/21
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 03/31/11
Due: 03/31/12
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 12/30/09
End: 02/11/11
Due: 02/11/12
Phase: N/A
Priority: Normal
Start: 05/16/17
End: 01/09/19
Due: 01/09/20
Phase: N/A
Priority: Normal
Start: 12/31/98
End: 04/30/09
Due: 04/30/10
Phase: N/A
Priority: Normal
Start: 12/19/18
End: 03/27/23
Due: 03/27/24
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Phase: N/A
Priority: Normal
Start: 09/10/14
End: 11/11/16
Due: 11/11/17
Phase: N/A
Priority: Normal
Start: 06/04/01
End: 05/06/04
Due: 05/06/05
Phase: N/A
Priority: Normal
Start: 09/09/10
End: 11/22/16
Due: 11/22/17
Phase: N/A
Priority: Normal
Start: 05/04/18
End: 11/23/21
Due: 11/23/22
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/03/14
End: 01/06/17
Due: 01/06/18
Phase: N/A
Priority: Normal
Start: 10/31/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/15/24
End: 09/09/24
Due: 09/09/25
Phase: N/A
Priority: Normal
Start: 11/24/20
End: 08/03/21
Due: 08/03/22
Phase: N/A
Priority: Normal
Start: 05/31/23
End: 05/14/27
Due: 05/14/28
Phase: N/A
Priority: Normal
Start: 07/26/22
End: 08/21/23
Due: 08/21/24
Phase: N/A
Priority: Normal
Start: 12/14/22
End: 12/29/26
Due: 12/29/27
Phase: N/A
Priority: Normal
Start: 10/07/11
End: 06/20/18
Due: 06/20/19